Mera - Ethical, accurate drug development

The Mera system automates the culture, drugging, and staining of 3D tissues on a large scale, enabling real-time monitoring and modular scalability for diverse tissue types.

Subsidie
€ 2.499.999
2023

Projectdetails

Introduction

Using patented fluid management technologies, the Mera system has the ability to culture, drug, and stain 3D tissues on a large scale while monitoring everything in real time through a fully automated fluorescent microscope.

System Components

3D microtissues are added to a dedicated consumable bio-plate. The plate is then integrated into the main Mera system.

Chemical Introduction

A chemical cocktail can be introduced to selected wells on a plate in order to mature the cells into different tissue types such as:

  • Liver
  • Heart
  • Neuronal
  • Cancer

Fluid Management

The fluid pathway can be changed to allow the introduction of a drug or stain to batches of multiple different tissue types. The fluid can then be recirculated, replicating the conditions in the human body where organs interact with each other.

Monitoring and Scalability

The whole process can be monitored using the automated microscope in wide field or fluorescent modes. The system is modular and scalable, allowing a single unit to run up to 800 microtissues simultaneously.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.499.999
Totale projectbegroting€ 4.158.818

Tijdlijn

Startdatum1-10-2023
Einddatum30-9-2025
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • HOOKE BIO LTDpenvoerder

Land(en)

Ireland

Vergelijkbare projecten binnen EIC Accelerator

EIC Accelerator

Multi-organ toxicity and efficacy test platform for Personalized medicine & Drug development

Cherry Biotech aims to revolutionize drug development and personalized medicine by providing a patented 3D cell culture platform that enhances predictability and reduces reliance on animal testing.

€ 2.499.831

Vergelijkbare projecten uit andere regelingen

ERC Proof of...

3D screening system to cultivate tissue and automatically stimulate and quantify its mechanical properties

The project aims to develop the TissMec system for automated 3D human tissue creation and screening to expedite drug candidate evaluation and improve the drug development process.

€ 150.000
Mkb-innovati...

Developing the ‘μMass’ microplate: combining cell therapy and organ-on-chip to treat cancer

Het project ontwikkelt een microplate voor in vitro celaggregaten en passieve flow om medicijnen en celtherapieën te testen.

€ 256.550
EIC Transition

IDEFIX Multiorgan toxicity and efficacy test platform

Cherry Biotech's IDEFIX project aims to revolutionize preclinical drug testing by developing a customizable organ-on-chip platform that mimics human multiorgan physiology, enhancing efficacy and toxicity predictions.

€ 2.496.073
Mkb-innovati...

Slim labinstrument voor 3D celculturen

IMcoMET onderzoekt de ontwikkeling van een kosteneffectief labinstrument voor continue, niet-destructieve metingen van fysiologische parameters in 3D-celculturen voor geneesmiddelonderzoek.

€ 20.000
ERC Proof of...

Development of a high-throughput microplate based device to analyse the patient derived tumour microenvironment

3DTUMOUR aims to enhance drug development success by providing patient-specific 3D bioprinted tumour models for ex vivo testing, improving treatment efficacy and reducing toxicity in cancer therapy.

€ 150.000